Peer-reviewed veterinary case report
Blood transfusions and outcomes in cats with hemoperitoneum 2018-2022
By Bunnell, Nicole et al.·Published in Frontiers in veterinary science·2023·Las Vegas Veterinary Specialty Center, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Blood product usage and factors associated with transfusions in cats with hemoperitoneum: 33 cases (2018-2022).
- Species:
- cat
Plain-English summary
A group of 33 cats diagnosed with hemoperitoneum (bleeding in the abdominal cavity) were treated at a veterinary hospital between 2018 and 2022. Many of these cats, particularly those with cancer, received blood transfusions, and those that did were more likely to survive their hospital stay. Despite various tests being performed, none were found to predict which cats would need a transfusion. Overall, the study highlights the importance of blood transfusions in improving outcomes for cats with this serious condition.
People also search for: cat hemoperitoneum treatment · cat blood transfusion survival rate · signs of bleeding in cats
Abstract
OBJECTIVE: To evaluate blood product usage in cats with hemoperitoneum. To secondarily evaluate factors associated with transfusion administration and the outcome of cats with hemoperitoneum. DESIGN: Retrospective study between the years 2018-2022. SETTING: University veterinary teaching hospital and private practice hospital. ANIMALS: 33 cats admitted to the hospital diagnosed with hemoperitoneum from January 2018 to September 2022. MEASUREMENTS AND MAIN RESULTS: Medical records were retrospectively reviewed; signalment, point-of-care diagnostics, effusion characteristics, and transfusion administration information was recorded. The most common etiology associated with hemoperitoneum was neoplasia (51.5%). Fifty-one percent (51.5%) of cats received a blood transfusion during hospitalization with the majority of cats receiving multiple transfusion types (69%). The etiology of hemoperitoneum was not associated with receiving a transfusion ( = 0.28) Point-of-care diagnostics including packed cell volume (PCV), total solids (TS) and platelet count were not significantly associated with receiving a transfusion ( = 0.317, = 0.11 and = 0.82, respectively). The PCV and TS of the effusion was also not significantly associated with transfusions ( = 0.91 and = 0.63, respectively). Sixteen cats (48%) survived to discharge. Transfusions were significantly associated with outcome and cats that received a transfusion were more likely to survive to discharge ( = 0.008). CONCLUSION: In conclusion, hemoperitoneum from a variety of etiologies in cats is associated with a high proportion of transfusions. None of the evaluated point-of-care diagnostics were associated with transfusion administration in this study. Cats that received a transfusion were more likely to survive to discharge.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/37520000/